Steatel oral solution

• primary (congenital) insufficiency of carnitine;
• secondary insufficiency of carnitine;
• cardiomyopathy.

Doses and duration of treatment are determined individually by the doctor, depending on the age and nosological form of the disease. Steatelle should be taken internally 30 minutes before eating. To dispense the drug use a dosing syringe or measuring cup. Adult drug should be administered at an initial dose of 1 g per day (10 ml), gradually increasing the dose depending on the patient's condition and tolerability. The usual dose of the drug for adults is 1–3 g (10-30 ml) per day, divided into 1–3 doses. The maximum daily dose for adults is 6 g (60 ml).

The average course of treatment for adults and children is 1–3 months. If necessary, the course of treatment can be repeated. In the case of primary and secondary carnitine insufficiency, the drug should be taken continuously or until the cause of the latter has been eliminated.

Children. The drug should be used for children (preterm and preterm infants) from the first day of life.

To appoint Steatel children starting at a dose of 50 mg/kg per day. The usual doses for children are 50–100 mg/kg per day.

The maximum daily dose for children is 3 g (30 ml).

Hypersensitivity to the drug components.

Active ingredient: levocarnitine;

1 ml of solution contains 100 mg of levocarnitine.

Excipients: malic acid, methylparaben (E 218), propylparaben (E 216), saccharin sodium, orange flavoring, water purified.

10 ml in a vial, 10 vials in a cardboard pack.

Do not store above 25 °C in light. Keep out of the reach of children.

Help, S.A., Pedini Ioanninon, Ioannina, 45500, Greece.

No 450 from 03/06/2018
Registration Certificate No. UA/12945/01/01